These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 1430395

  • 1. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
    Zic J, Arzubiaga C, Salhany KE, Parker RA, Wilson D, Stricklin GP, Greer J, King LE.
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):729-36. PubMed ID: 1430395
    [Abstract] [Full Text] [Related]

  • 2. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G, Carabelli A, Berti E, Guizzardi M, Fossati S, De Filippo C, Bertani E.
    Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy.
    Zic JA, Stricklin GP, Greer JP, Kinney MC, Shyr Y, Wilson DC, King LE.
    J Am Acad Dermatol; 1996 Dec; 35(6):935-45. PubMed ID: 8959953
    [Abstract] [Full Text] [Related]

  • 4. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience.
    Jiang SB, Dietz SB, Kim M, Lim HW.
    Photodermatol Photoimmunol Photomed; 1999 Oct; 15(5):161-5. PubMed ID: 10540936
    [Abstract] [Full Text] [Related]

  • 5. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
    Bisaccia E, Gonzalez J, Palangio M, Schwartz J, Klainer AS.
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
    [Abstract] [Full Text] [Related]

  • 6. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
    Wilson LD, Licata AL, Braverman IM, Edelson RL, Heald PW, Feldman AM, Kacinski BM.
    Int J Radiat Oncol Biol Phys; 1995 Jul 15; 32(4):987-95. PubMed ID: 7607973
    [Abstract] [Full Text] [Related]

  • 7. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
    Prinz B, Behrens W, Hölzle E, Plewig G.
    Arch Dermatol Res; 1995 Jul 15; 287(7):621-6. PubMed ID: 8534123
    [Abstract] [Full Text] [Related]

  • 8. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma.
    Seremet S, Abhyankar S, Herd TJ, Aires D.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1212-1216. PubMed ID: 27741338
    [Abstract] [Full Text] [Related]

  • 9. Extracorporeal photochemotherapy--the Columbia Presbyterian experience.
    Knobler E, Warmuth I, Cocco C, Miller B, Mackay J.
    Photodermatol Photoimmunol Photomed; 2002 Oct 01; 18(5):232-7. PubMed ID: 12390664
    [Abstract] [Full Text] [Related]

  • 10. Photopheresis for the treatment of cutaneous T cell lymphoma.
    Armus S, Keyes B, Cahill C, Berger C, Crater D, Scarborough D, Klainer A, Bisaccia E.
    J Am Acad Dermatol; 1990 Nov 01; 23(5 Pt 1):898-902. PubMed ID: 2147701
    [Abstract] [Full Text] [Related]

  • 11. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy.
    Heald P, Rook A, Perez M, Wintroub B, Knobler R, Jegasothy B, Gasparro F, Berger C, Edelson R.
    J Am Acad Dermatol; 1992 Sep 01; 27(3):427-33. PubMed ID: 1401279
    [Abstract] [Full Text] [Related]

  • 12. Extracorporeal photopheresis--a new approach for the treatment of cutaneous T cell lymphomas.
    Gollnick HP, Owsianowski M, Ramaker J, Chun SC, Orfanos CE.
    Recent Results Cancer Res; 1995 Sep 01; 139():409-15. PubMed ID: 7597308
    [Abstract] [Full Text] [Related]

  • 13. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U, Looks A, Meyer J, Knopf B, Koch HJ, Liebold K, Hipler UC.
    J Am Acad Dermatol; 2001 Feb 01; 44(2):253-60. PubMed ID: 11174383
    [Abstract] [Full Text] [Related]

  • 14. Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019.
    Girardi M, Carlson K, Huang X, Corman SL, Edmundson P, Schmier J, Kale HP, Raina R, Foss F.
    J Dermatolog Treat; 2024 Dec 01; 35(1):2360568. PubMed ID: 38852942
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
    Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG, Lessin SR, Rook AH.
    J Am Acad Dermatol; 1996 Dec 01; 35(6):946-57. PubMed ID: 8959954
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA.
    Dermatol Clin; 2015 Oct 01; 33(4):765-76. PubMed ID: 26433848
    [Abstract] [Full Text] [Related]

  • 19. Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy.
    Wollina U, Liebold K, Kaatz M, Looks A, Stuhlert A, Lange D.
    Oncol Rep; 2000 Oct 01; 7(6):1197-201. PubMed ID: 11032913
    [Abstract] [Full Text] [Related]

  • 20. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L.
    Skin Therapy Lett; 2007 Jun 01; 12(5):1-4. PubMed ID: 17609808
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.